✦ LIBER ✦

Phase I Trial Using the Proteasome Inhibitor Bortezomib and Concurrent Chemoradiotherapy for Head-and-Neck Malignancies

✍ Scribed by Gregory J. Kubicek; Rita S. Axelrod; Mitchell Machtay; Peter H. Ahn; Pramila R. Anne; Shannon Fogh; David Cognetti; Thomas J. Myers; Walter J. Curran Jr.; Adam P. Dicker

Book ID: 118456912
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 202 KB
Volume: 83
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2011.09.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Induction chemotherapy followed by concu

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

✍ Haddad, Robert; O'Neill, Anne; Rabinowits, Guilherme; Tishler, Roy; Khuri, Fadlo 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 253 KB

Phase I trial of concurrent chemoradioth

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

✍ Katori, H; Tsukuda, M; Mochimatu, I; Ishitoya, J; Kawai, S; Mikami, Y; Matsuda, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phase I trial of the proteasome inhibito

Phase I trial of the proteasome inhibitor bortezomib in combination with carboplatin in patients with platinum- and taxane-resistant ovarian cancer

✍ Pedro T. Ramirez; Charles N. Landen Jr.; Robert L. Coleman; Michael R. Milam; Ch 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Multi-agent concurrent chemoradiotherapy

Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly

✍ Stephanie A. Michal; David J. Adelstein; Lisa A. Rybicki; Cristina P. Rodriguez; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

A phase I and pharmacologic study of seq

A phase I and pharmacologic study of sequences of the proteasome inhibitor, bortezomib (PS-341, Velcade™), in combination with paclitaxel and carboplatin in patients with advanced malignancies

✍ Cynthia Ma; Sumithra J. Mandrekar; Steven R. Alberts; Gary A. Croghan; Aminah Ja 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 310 KB

Single-arm phase II study of multiagent

Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck

✍ Cristina P. Rodriguez; David J. Adelstein; Lisa A. Rybicki; Jerrold P. Saxton; R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB